CLDI

2.44% -0.0174

Handel nachbörslich: .69 -0.006 -0.86%

Calidi Biotherapeutics Inc (CLDI)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Calidi Biotherapeutics Inc Stock (CLDI) Company Profile

Calidi Biotherapeutics Inc

Healthcare (1161)

Biotechnology (653)

(858) 794-9600

4475 Executive Drive, Suite 200, San Diego

Nächster Verdiensttermin

Neueste SEC-Einreichungen

CLDI's Discussions on Twitter

Vergleichen Sie CLDI mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
CLDI Calidi Biotherapeutics Inc	0.696	19.75M	0	-23.36M	0	-0.7368
VRTX Vertex Pharmaceuticals Inc	470.13	119.21B	11.10B	-988.90M	-1.26B	-3.92
REGN Regeneron Pharmaceuticals Inc	560.93	59.16B	14.09B	4.50B	2.96B	39.28
ALNY Alnylam Pharmaceuticals Inc	325.28	40.57B	2.35B	-269.70M	-75.39M	-2.09
ARGX Argen X Se Adr	571.23	34.02B	2.58B	1.06B	-1.28B	16.33
ONC Beone Medicines Ltd Adr	295.59	29.19B	3.81B	-644.79M	-669.77M	-6.24

Calidi Biotherapeutics Inc Stock (CLDI) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2023-11-22	Eingeleitet	H.C. Wainwright	Buy
2023-10-09	Eingeleitet	Robert W. Baird	Outperform

Calidi Biotherapeutics Inc Aktie (CLDI) Neueste Nachrichten

Finanzdaten der Calidi Biotherapeutics Inc-Aktie (CLDI)

Calidi Biotherapeutics Inc (CLDI)

Calidi Biotherapeutics Inc Stock (CLDI) Company Profile

Vergleichen Sie CLDI mit anderen Aktien

Calidi Biotherapeutics Inc Stock (CLDI) Upgrades & Downgrades

Calidi Biotherapeutics Inc Aktie (CLDI) Neueste Nachrichten

What analysts say about Calidi Biotherapeutics Inc. stockTriple-digit profit margins - jammulinksnews.com

What drives Calidi Biotherapeutics Inc. stock priceConsistent wealth multiplication - jammulinksnews.com

Calidi Biotherapeutics Invites Investors to Webinar on Precision Genetic Medicine Advances - Nasdaq

Join Calidi Biotherapeutics’ Exclusive Live Investor Webinar and Q&A Session on July 24 - GlobeNewswire

Is Calidi Biotherapeutics Inc. a good long term investmentSuperior returns - Autocar Professional

Calidi Biotherapeutics Inc. Stock Analysis and ForecastExplosive portfolio gains - Autocar Professional

What risks could impact Calidi Biotherapeutics Inc. stock performanceFree Stock Trading Community - Newser

What makes Calidi Biotherapeutics Inc. stock price move sharplyFree Professional Portfolio Management - Newser

Why Calidi Biotherapeutics Inc. stock attracts strong analyst attentionFree Best Performing Stock Suggestions - Newser

How Calidi Biotherapeutics Inc. stock performs during market volatilityMarket Beating Strategy - Newser

Calidi Biotherapeutics Inc Inc. (CLDI) Price Performance: A Comparative Analysis with Competitors - investchronicle.com

Calidi Biotherapeutics Approves Key Proposals at Annual Meeting - TipRanks

Calidi Biotherapeutics Plummets 27%—Can Biotech Breakthroughs Stem the Slide? - AInvest

Calidi Biotherapeutics Plunges 4.81% Amid Bridge Financing - AInvest

Top Penny Stocks To Add to Your Watchlist – July 9th - Defense World

MarketsMedicine Hat News - FinancialContent

Calidi Biotherapeutics Announces Inducement Offer Agreement - TipRanks

Cancer Innovation Accelerates as Funding Cuts Loom and Biotechs Step Up - Quantisnow

Calidi Biotherapeutics: Redefining Cancer Treatment with Breakthrough Virotherapy - AInvest

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Platform Designed to Transform Landscape of Cancer Treatment - The Manila Times

Breakthrough Cancer Treatment: Calidi's New Genetic Platform Targets Both Primary and Metastatic Tumors - Stock Titan

Calidi Biotherapeutics Secures $4.6 Million Through Warrant Exercise Agreement - citybuzz -

Calidi Biotherapeutics Cashes In On Warrant Agreement - Finimize

Calidi Biotherapeutics secures $4.6 million through warrant exercise - Investing.com Australia

Calidi Biotherapeutics secures $4.6 million through warrant exercise By Investing.com - Investing.com Nigeria

Calidi Biotherapeutics to Raise $4.6 Million Through Warrant Exercise Agreement - MarketScreener

Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers - The Malaysian Reserve

Calidi Biotherapeutics Announces Exercise of Warrants for $4.6 Million of Gross Proceeds - The Manila Times

Clinical-Stage Biotech Calidi Raises $4.6M in Fresh Capital: Accelerates Targeted Therapy Programs - Stock Titan

Crude Oil Moves Higher; RxSight Shares Plunge - Benzinga

Dow Jumps 200 Points; US Wholesale Inventories Fall 0.3% In May - Benzinga

Finanzdaten der Calidi Biotherapeutics Inc-Aktie (CLDI)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie CLDI